Genetic Technologies Limited(NASDAQ:GENE) 
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary ...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-12
P
O 1.09
H 1.14
L 0.75
C 0.80
V 773,280
10EMA 0.80
20EMA 0.80
60EMA 0.80
120EMA 0.80
250EMA 0.80